Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $160.63 | 4 | 84.1% |
| Education | $30.44 | 2 | 15.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $120.61 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $25.02 | 2 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $19.69 | 1 | $0 (2021) |
| AKEBIA THERAPEUTICS INC | $15.00 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $10.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $135.61 | 2 | Novo Nordisk Inc ($120.61) |
| 2021 | $33.49 | 2 | Aurinia Pharma U.S., Inc. ($19.69) |
| 2019 | $11.22 | 1 | AstraZeneca Pharmaceuticals LP ($11.22) |
| 2018 | $10.75 | 1 | Otsuka America Pharmaceutical, Inc. ($10.75) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $120.61 | General |
| Category: Diabetes | ||||||
| 07/28/2022 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Nephrology | ||||||
| 10/01/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Education | In-kind items and services | $19.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/24/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $10.75 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 399 | 942 | $202,160 | $102,912 |
| 2022 | 8 | 467 | 1,056 | $217,464 | $108,850 |
| 2021 | 9 | 540 | 1,245 | $294,156 | $144,773 |
| 2020 | 8 | 502 | 1,146 | $239,299 | $117,647 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 108 | $57,240 | $28,566 | 49.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 223 | $35,680 | $20,308 | 56.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 293 | $32,230 | $17,741 | 55.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 52 | $22,880 | $11,660 | 51.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 110 | $22,000 | $10,771 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 79 | $15,010 | $6,853 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 37 | $9,640 | $4,818 | 50.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 22 | 40 | $7,480 | $2,194 | 29.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 31 | 123 | $65,190 | $33,693 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 290 | $46,335 | $22,930 | 49.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 116 | 332 | $36,520 | $18,230 | 49.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 104 | 125 | $25,000 | $13,044 | 52.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 47 | $20,680 | $10,613 | 51.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 72 | $12,240 | $6,414 | 52.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 21 | 52 | $9,724 | $2,931 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $1,775 | $995.07 | 56.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 45 | 227 | $129,274 | $62,881 | 48.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 130 | 402 | $44,220 | $22,453 | 50.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 112 | 237 | $37,855 | $19,142 | 50.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 102 | 119 | $23,800 | $12,632 | 53.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 24 | 47 | $19,286 | $10,476 | 54.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 65 | $10,400 | $6,177 | 59.4% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 40 | 108 | $20,196 | $6,040 | 29.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 25 | $5,375 | $3,126 | 58.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $3,750 | $1,845 | 49.2% |
About Dr. Joseph Moss, M.D
Dr. Joseph Moss, M.D is a Nephrology healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679548853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Moss, M.D has received a total of $191.07 in payments from pharmaceutical and medical device companies, with $135.61 received in 2022. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($160.63).
As a Medicare-enrolled provider, Moss has provided services to 1,908 Medicare beneficiaries, totaling 4,389 services with total Medicare billing of $474,182. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Latrobe, PA
- Active Since 02/21/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679548853
Products in Payments
- Ozempic (Drug) $120.61
- LOKELMA (Drug) $25.02
- LUPKYNIS (Drug) $19.69
- Auryxia (Drug) $15.00
- SAMSCA (Drug) $10.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.